We know that a family history of prostate cancer and the presence of certain genetic/genomic markers are associated with increased risk for prostate cancer in general and for some types of clinically significant prostate cancer in particular. We also know that: PSA testing may lead to a reduction in prostate cancer-specific mortality rates, but also […]![]()
